Type of Gonadotropin and Embryo Kinetics of Development (PEM-ESD)
A Prospective Randomized Trial to Analyze the Effect of the Gonadotropin Administered During Control Ovarian Stimulation on Embryo Kinetics of Development
Sponsor: IVI Madrid
Terminated
This trial was terminated. No reason was provided.
Listed as NCT02402192, this PHASE4 trial focuses on Infertility and remains terminated or withdrawn. Sponsored by IVI Madrid, it has been updated 7 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Sep 2022 — Jul 2024 [monthly]
Terminated PHASE4
Status: Unknown Status → Terminated
-
Jan 2021 — Sep 2022 [monthly]
Unknown Status PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE4
▶ Show 2 earlier versions
-
May 2017 — Jun 2018 [monthly]
Unknown Status PHASE4
Status: Not Yet Recruiting → Unknown Status
-
Jan 2017 — May 2017 [monthly]
Not Yet Recruiting PHASE4
First recorded
Apr 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- IVI Madrid
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.